Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
Author(s): McPherson Timothy B, Neumann William L, Kolling William M
Issue: Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue
Page(s): 508-511
Download in electronic PDF format for $75
Abstract: Tetracaine topical solution may improve patient adherence with topical clotrimazole therapy for fungal otitis externa. The chemical stability of tetracaine 1% and combination clotrimazole 1% with tetracaine 1% topical solutions was determined using a stability-indicating high-performance liquid chromatography assay. Propylene glycol and polyethylene glycol 400 were used as anhydrous solvents. Standard curves for tetracaine and clotrimazole were linear with r2 = 0.999. Clotrimazole did not degrade in either propylene glycol or polyethylene glycol 400 throughout the 90-day study period. Tetracaine degraded significantly in propylene glycol but not in polyethylene glycol 400. A beyond-use date of 90 days is supported for tetracaine and the combination clotrimazole-tetracaine solution in polyethylene glycol 400. A beyond-use date of 60 days is supported for tetracaine and the combination clotrimazole–tetracaine in propylene glycol.
Related Keywords:
tetracaine, clotrimazole, topical solutions, topical preparations, patient adherence, fungal otitis externa, stability, propylene glycol, polyethylene glycol 400, PEG 400, topical anesthetic, drug admixtures
Related Categories:
EXCIPIENTS, PACKAGING, PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Kinetics of Tetracaine Solvolysis in Propylene Glycol
McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M
|
Jul/Aug 2018
Pg. 329-334
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 73
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel
Allen Loyd V Jr
|
Mar/Apr 1998
Pg. 159
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 489
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 319
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 44
|
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 476
|
Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine
Rudner Shara, Pora Amanda, DeMeo Jennifer
|
Mar/Apr 2011
Pg. 114-116
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2024
Pg. 490
|
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 310
|
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients
Muller George, Case Tyler, Deen Griffin L
|
Sep/Oct 2010
Pg. 395-399
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Return to Top |